Singapore endorses Pfizer-BioNTech COVID-19 antibody for use in 12 to 15-year-olds Kumar Jeetendra | May 18, 2021 Singapore has authorised the use of the Pfizer-BioNTech COVID-19 vaccine for those aged 12 to 15 years old in a bid to extend protection to more groups as the country tackles a recent increase of infections, officials said on Tuesday.“The data showed that the Pfizer-BioNTech COVID-19 vaccine demonstrated high efficacy consistent with that observed in …
New COVID-19 testing innovation is a less expensive, quicker choice to tube-based RT-PCR tests Kumar Jeetendra | May 18, 2021 Throughout the COVID-19 pandemic, supply chain shortages of reagents and test kits have restricted the rapid expansion of clinical testing required to contain the virus. Its accuracy was 100 percent predictive in clinical trials, researchers explain in The Journal of Molecular Diagnostics, published by Elsevier. Sensitivity is critical for early detection of COVID-19 infection where …
Researchers develop experimental direct-acting antiviral treatment to treat COVID-19 Kumar Jeetendra | May 18, 2021 An international team of scientists from the Menzies Health Institute Queensland (MHIQ) at Griffith University and from City of Hope, a research and treatment center for cancer, diabetes and other life-threatening diseases in the U.S., have developed an experimental direct-acting antiviral therapy to treat COVID-19. Conventional antivirals reduce symptoms and help people recover earlier. Examples …
Lonza Launches Next Generation 4D-Nucleofector Cell Transfection Platform with Proven Performance and Enhanced Ease of Use Kumar Jeetendra | May 18, 2021 Basel, Switzerland, 18 May 2021 – Lonza has launched the next generation of its popular Nucleofector® Platform. For more than 20 years, Nucleofector® Technology has led the market as the most effective non-viral cell transfection method, which can be used even for hard-to-transfect cells, such as primary cells and pluripotent stem cells. Now, with an …
Optimus Pharma gets DCGI gesture to lead Phase-3 preliminary of COVID-19 antiviral drug Kumar Jeetendra | May 19, 2021 The orally administered drug is being tested for treating mild and moderate infection Optimus Pharma has obtained the approval of the Drug Controller General of India (DCGI) to conduct Phase III clinical trials of orally administered Molnupiravir capsules on patients with mild and moderate Covid-19 infection. In accordance with the clinical trial protocols approved, a …
New medication like compound could adequately hinder a critical step in malaria parasite life cycle Kumar Jeetendra | May 19, 2021 Researchers at the Francis Crick Institute and the Latvian Institute of Organic Synthesis have designed a drug-like compound which effectively blocks a vital step in the malaria parasite life cycle and are working to develop this compound into a potential first of its type malaria treatment. While drugs and mosquito control have reduced levels of …
System Performance Qualification – Removing Uncertainty from Your Results Kumar Jeetendra | May 19, 2021 TESTA Analytical Solutions e.K. reports on widespread interest from European laboratories for performance qualifying their particle size, zeta potential and GPC/SEC instruments. The COVID-19 pandemic has had a huge effect on the daily operations of most laboratories. Restrictions concerning personnel on site has had a major impact on proven processes and standard operating procedures (SOP). …
Cipla launches ‘ViraGen’ a polymerase chain reaction (Covid-19 RT-PCR) test Kumar Jeetendra | May 20, 2021 Mumbai, India; May 20 2021: Cipla Limited (BSE: 500087; NSE: CIPLA EQ, referred to as “Cipla”) today announced the commercialisation of a polymerase chain reaction (RT-PCR) test kit ‘ViraGen’ for COVID-19 in India, in partnership with Ubio Biotechnology Systems Pvt. Ltd. ViraGen is Cipla’s third offering in the Covid-19 testing segment. Cipla already has partnerships …
Vasu Healthcare takes several initiatives to support its employees during Covid Kumar Jeetendra | May 20, 2021 20 May 2021: Vadodara based Vasu Healthcare Pvt Ltd – a leading company in herbal and ayurveda space has taken several initiatives to support its employees and their families in battling Covid-19. Company has taken measures including special paid leaves, reimbursements of medical tests, financial support, testing & hospitalisation for the needy employees among others. …
Indica Labs and Ibex Partner to Deliver AI-powered Clinical Workflows for Digital Pathology Kumar Jeetendra | May 20, 2021 ALBUQUERQUE, NM and TEL AVIV, Israel – May 20, 2021 – Life Science Newswire – Indica Labs, an industry leader in quantitative digital pathology & image management solutions, and Ibex Medical Analytics, a pioneer in artificial intelligence (AI) based cancer diagnostics, announced an agreement to integrate the Galen™ AI-based cancer diagnostics platform into the HALO …
India faces antifungal drug shortage as Black Fungus cases add to COVID-19 troubles Kumar Jeetendra | May 21, 2021 India said on May 21 that it is working to alleviate a shortage of a medicine used to treat a rare fungal disease hitting COVID-19 patients as the healthcare system is reeling under a massive wave of coronavirus infections. Cases of Mucormycosis, or Black Fungus, a potentially serious complication that causes blurred or double vision, …
Stressed brains can be retrained to think positive, shows new examination Kumar Jeetendra | May 21, 2021 Worried brains could be retrained to react to everyday situations in a less threatening way to reduce anxiety levels, according to new research published by researchers from The University of Western Australia and the University of Virginia. The study, published in Behavior Research and Therapy, reported on the first feasibility and effectiveness of a free …
